MX9603480A - Procedimiento para preparar formulaciones farmaceuticas en particulas finas. - Google Patents
Procedimiento para preparar formulaciones farmaceuticas en particulas finas.Info
- Publication number
- MX9603480A MX9603480A MX9603480A MX9603480A MX9603480A MX 9603480 A MX9603480 A MX 9603480A MX 9603480 A MX9603480 A MX 9603480A MX 9603480 A MX9603480 A MX 9603480A MX 9603480 A MX9603480 A MX 9603480A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical formulations
- fine particle
- preparing fine
- particle pharmaceutical
- degree
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un procedimiento para preparar formulaciones farmacéuticas en partículas finas que tiene una produccion mejorada y que produce una uniformidad mayor de tamaño de partícula, comprende añadir a los componentes en seco de la formulacion, antes de los pasos de humedecimiento, extrusion, y esferonizacion, un material auxiliar de extrusion seleccionado de aceites y ceras farmacéuticamente aceptables que tienen un punto de caída de entre aproximadamente 15 degree C y 115 degree C.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19702594A | 1994-02-16 | 1994-02-16 | |
PCT/US1995/001943 WO1995022319A1 (en) | 1994-02-16 | 1995-02-14 | Process for preparing fine particle pharmaceutical formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9603480A true MX9603480A (es) | 1997-12-31 |
Family
ID=22727703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9603480A MX9603480A (es) | 1994-02-16 | 1995-02-14 | Procedimiento para preparar formulaciones farmaceuticas en particulas finas. |
Country Status (11)
Country | Link |
---|---|
US (1) | US6063313A (es) |
EP (1) | EP0744941B1 (es) |
JP (1) | JP4040084B2 (es) |
AT (1) | ATE241962T1 (es) |
CA (1) | CA2182282C (es) |
DE (1) | DE69530973T2 (es) |
DK (1) | DK0744941T3 (es) |
ES (1) | ES2199981T3 (es) |
MX (1) | MX9603480A (es) |
PT (1) | PT744941E (es) |
WO (1) | WO1995022319A1 (es) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19531277A1 (de) * | 1995-08-25 | 1997-02-27 | Basf Ag | Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren |
EP1014941B2 (en) | 1996-06-26 | 2017-05-17 | The Board Of Regents, The University Of Texas System | Hot-melt extrudable pharmaceutical formulation |
US6139872A (en) * | 1996-08-14 | 2000-10-31 | Henkel Corporation | Method of producing a vitamin product |
FR2753904B1 (fr) * | 1996-10-01 | 1998-10-30 | Gattefosse Ets Sa | Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication |
IT1298574B1 (it) * | 1998-02-06 | 2000-01-12 | Vectorpharma Int | Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione |
DK1073513T3 (da) * | 1998-04-24 | 2003-12-22 | Basf Corp | Forbedret ekstruderingsproces |
JP2000128774A (ja) * | 1998-10-26 | 2000-05-09 | Tanabe Seiyaku Co Ltd | 薬物を含有する球形微粒子の製法 |
SI20150A (sl) * | 1999-02-19 | 2000-08-31 | Lek, Tovarna Farmacevtskih In | Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina |
US7658938B2 (en) * | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
AU4028300A (en) | 1999-03-26 | 2000-10-16 | Nutrasweet Company, The | Particles of n-(n-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine 1-methylester |
DE19916383A1 (de) * | 1999-03-31 | 2000-10-05 | Schering Ag | Pharmazeutische Zusammensetzung mit einem Extrusionsstoff |
WO2001034119A2 (en) | 1999-11-12 | 2001-05-17 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
KR20030011797A (ko) * | 2000-03-28 | 2003-02-11 | 바이오케미 게젤샤프트 엠베하 | 맛이 차폐된 과립형 입자 |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
WO2002024174A2 (en) * | 2000-09-22 | 2002-03-28 | Galephar M/F | Sustained release composition containing clarithromycin |
FR2816507B1 (fr) | 2000-11-16 | 2003-02-28 | Ethypharm Lab Prod Ethiques | Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules |
ITRN20000051A1 (it) | 2000-12-22 | 2002-06-22 | Ascor Chimici Srl | Metodo e apparecchiatura per formare sferule composite contenenti principi attivi del tipo farmaceutico e/o integratori alimentari o cosmeti |
EP1392272B1 (en) | 2001-05-11 | 2014-08-06 | Merrion Research III Limited | Permeation enhancers |
US20030203019A1 (en) * | 2002-04-30 | 2003-10-30 | Cornelius John Mark | Coated conditioners for use in foods and pharmaceuticals |
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
CA2514875A1 (en) * | 2003-02-19 | 2004-09-02 | Biovail Laboratories International Srl | Rapid absorption selective 5-ht agonist formulations |
EP2535042A1 (en) | 2003-06-16 | 2012-12-19 | ANDRX Pharmaceuticals LLC. | Oral sustained-release composition comprising a macrolide |
US20060165790A1 (en) * | 2003-06-27 | 2006-07-27 | Malcolm Walden | Multiparticulates |
TWI357815B (en) * | 2003-06-27 | 2012-02-11 | Euro Celtique Sa | Multiparticulates |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE102004032051A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
WO2005023221A1 (en) * | 2003-09-05 | 2005-03-17 | Ranbaxy Laboratories Limited | Clarithromycin formulations having improved biovailability |
GB2411355B (en) | 2004-02-27 | 2006-02-22 | Niche Generics Ltd | Pharmaceutical composition |
US7491263B2 (en) * | 2004-04-05 | 2009-02-17 | Technology Innovation, Llc | Storage assembly |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
GB2418854B (en) | 2004-08-31 | 2009-12-23 | Euro Celtique Sa | Multiparticulates |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE102006006532B4 (de) * | 2006-02-10 | 2007-11-08 | Biogenerics Pharma Gmbh | Pharmazeutische Zubereitung |
JP5450052B2 (ja) | 2006-04-07 | 2014-03-26 | メリオン リサーチ Iii リミテッド | 強化剤を含む固体経口投与剤形 |
SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
US20080131504A1 (en) * | 2006-12-01 | 2008-06-05 | Mission Pharmacal Co. | Short Term Slow Release Drug Delivery System |
TWI454288B (zh) | 2008-01-25 | 2014-10-01 | Gruenenthal Chemie | 藥物劑型 |
US8999383B2 (en) | 2008-05-07 | 2015-04-07 | Merrion Research Iii Limited | Compositions of GnRH related compounds and processes of preparation |
EP2273983B1 (en) | 2008-05-09 | 2016-07-20 | Grünenthal GmbH | Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step |
ES2560210T3 (es) | 2009-07-22 | 2016-02-17 | Grünenthal GmbH | Forma de dosificación resistente a la manipulación para opiádes sensibles a la oxidación |
CN102573805A (zh) | 2009-07-22 | 2012-07-11 | 格吕伦塔尔有限公司 | 热熔挤出的控制释放剂型 |
EP2516494B1 (en) * | 2009-12-23 | 2016-06-01 | Essilor International (Compagnie Générale D'Optique) | Method of converting a polymerizable composition into thermoplastic polyurethane of improved yellowness index and article obtained by this method |
WO2011120033A1 (en) | 2010-03-26 | 2011-09-29 | Merrion Research Iii Limited | Pharmaceutical compositions of selective factor xa inhibitors for oral administration |
TWI516286B (zh) | 2010-09-02 | 2016-01-11 | 歌林達股份有限公司 | 含陰離子聚合物之抗破碎劑型 |
ES2486791T3 (es) | 2010-09-02 | 2014-08-19 | Grünenthal GmbH | Forma de dosificación resistente a la manipulación que comprende una sal inorgánica |
JP2014501784A (ja) | 2011-01-07 | 2014-01-23 | メリオン・リサーチ・Iii・リミテッド | 経口投与用の鉄の医薬組成物 |
CA2839126A1 (en) | 2011-07-29 | 2013-02-07 | Grunenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
DK2736495T3 (da) | 2011-07-29 | 2017-11-13 | Gruenenthal Gmbh | Misbrugsbestandig tablet som tilvejebringer øjeblikkelig frigivelse af lægemiddel |
WO2013127831A1 (en) | 2012-02-28 | 2013-09-06 | Grünenthal GmbH | Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer |
JP6282261B2 (ja) | 2012-04-18 | 2018-02-21 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 不正使用防止および過量放出防止医薬剤形 |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
CA2907950A1 (en) | 2013-05-29 | 2014-12-04 | Grunenthal Gmbh | Tamper-resistant dosage form containing one or more particles |
AU2014273226B2 (en) | 2013-05-29 | 2019-06-27 | Grunenthal Gmbh | Tamper resistant dosage form with bimodal release profile |
CN105682643B (zh) | 2013-07-12 | 2019-12-13 | 格吕伦塔尔有限公司 | 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型 |
JP6480936B2 (ja) | 2013-11-26 | 2019-03-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | クライオミリングによる粉末状医薬組成物の調製 |
WO2015173195A1 (en) | 2014-05-12 | 2015-11-19 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
CN106456550A (zh) | 2014-05-26 | 2017-02-22 | 格吕伦塔尔有限公司 | 避免乙醇剂量倾泻的多颗粒 |
WO2016120378A1 (en) | 2015-01-29 | 2016-08-04 | Novo Nordisk A/S | Tablets comprising glp-1 agonist and enteric coating |
CN107889459A (zh) | 2015-04-24 | 2018-04-06 | 格吕伦塔尔有限公司 | 具有立即释放和对溶剂萃取的抗性的抗篡改剂型 |
US10842750B2 (en) | 2015-09-10 | 2020-11-24 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB757165A (en) * | 1953-10-30 | 1956-09-12 | Abbott Lab | Compositions of erythromycin for combating bacterial infections |
US4374082A (en) * | 1981-08-18 | 1983-02-15 | Richard Hochschild | Method for making a pharmaceutical and/or nutritional dosage form |
FR2581541B1 (fr) * | 1985-05-09 | 1988-05-20 | Rhone Poulenc Sante | Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation |
DE3524572A1 (de) * | 1985-07-10 | 1987-01-15 | Thomae Gmbh Dr K | Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung |
US4686231A (en) * | 1985-12-12 | 1987-08-11 | Smithkline Beckman Corporation | Inhibition of 5-lipoxygenase products |
US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
IL84944A (en) * | 1987-01-19 | 1992-02-16 | Ici Plc | Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation |
IT1226549B (it) * | 1988-07-12 | 1991-01-24 | Resa Farma | Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose. |
US5126145A (en) * | 1989-04-13 | 1992-06-30 | Upsher Smith Laboratories Inc | Controlled release tablet containing water soluble medicament |
US5002774A (en) * | 1989-06-08 | 1991-03-26 | Erbamont, Inc. | Sustained release pharmaceutical tablet |
US5169645A (en) * | 1989-10-31 | 1992-12-08 | Duquesne University Of The Holy Ghost | Directly compressible granules having improved flow properties |
FR2657257B1 (fr) * | 1990-01-19 | 1994-09-02 | Rhone Poulenc Sante | Procede de preparation de medicaments sous forme de perles. |
FR2663818B1 (fr) * | 1990-06-29 | 1993-07-09 | Rhone Poulenc Nutrition Animale | Procede de preparation de granules de principes actifs par extrusion. |
JP3265680B2 (ja) * | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | 経口製剤用組成物 |
US5292900A (en) * | 1992-12-18 | 1994-03-08 | Abbott Laboratories | O-substituted N-hydroxyurea derivatives |
-
1995
- 1995-02-14 DK DK95909559T patent/DK0744941T3/da active
- 1995-02-14 JP JP52190295A patent/JP4040084B2/ja not_active Expired - Fee Related
- 1995-02-14 MX MX9603480A patent/MX9603480A/es not_active IP Right Cessation
- 1995-02-14 EP EP95909559A patent/EP0744941B1/en not_active Expired - Lifetime
- 1995-02-14 WO PCT/US1995/001943 patent/WO1995022319A1/en active IP Right Grant
- 1995-02-14 AT AT95909559T patent/ATE241962T1/de not_active IP Right Cessation
- 1995-02-14 ES ES95909559T patent/ES2199981T3/es not_active Expired - Lifetime
- 1995-02-14 PT PT95909559T patent/PT744941E/pt unknown
- 1995-02-14 DE DE69530973T patent/DE69530973T2/de not_active Expired - Fee Related
- 1995-02-14 CA CA002182282A patent/CA2182282C/en not_active Expired - Fee Related
-
1996
- 1996-05-30 US US08/655,491 patent/US6063313A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
PT744941E (pt) | 2003-10-31 |
ATE241962T1 (de) | 2003-06-15 |
DE69530973D1 (de) | 2003-07-10 |
DK0744941T3 (da) | 2003-09-29 |
CA2182282A1 (en) | 1995-08-24 |
EP0744941A1 (en) | 1996-12-04 |
EP0744941B1 (en) | 2003-06-04 |
CA2182282C (en) | 2006-04-18 |
JPH09509176A (ja) | 1997-09-16 |
WO1995022319A1 (en) | 1995-08-24 |
JP4040084B2 (ja) | 2008-01-30 |
US6063313A (en) | 2000-05-16 |
ES2199981T3 (es) | 2004-03-01 |
DE69530973T2 (de) | 2004-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9603480A (es) | Procedimiento para preparar formulaciones farmaceuticas en particulas finas. | |
GB9421836D0 (en) | Process for preparing solid pharmaceutical dosage forms of hydrophobic substances | |
CA2137826A1 (en) | Process for production of medicament formulations | |
SI0773025T1 (en) | New stable galenic formulations containing an acid-labile benzimidazol compound, and production process | |
HUT53362A (en) | Process for producing substituted 1,3-oxathiolans and pharmaceutical compositions comprising same | |
AU623967B2 (en) | Process and spray drying apparatus for producing stable particle agglomerates | |
ZA959073B (en) | Process for preparing solid pharmaceutical dosage forms | |
HUT59000A (en) | Process for producing pharmaceutical preparations containing 4-phenyl-1,2,3,4-tetrahydro-1-naphtalinamine-derivatives | |
AU2793397A (en) | Fine ultraviolet screening particles, process for preparing the same, and cosmetic preparation | |
AU5337796A (en) | Polyaminoacid-based particles for use as active principle vectors, and methods for preparing same | |
HUP9903671A3 (en) | Antagonists of gonadotropin releasing hormone, pharmaceutical compositions and process for producing them | |
HUP9601884A3 (en) | 6-(dimethylamino-methyl)-1-phenyl-cyclohexane compounds, their use as pharmaceutically active analgetic matarials and process for their preparation | |
NZ332480A (en) | Dispersible macromolecule compositions and methods for their preparation and use | |
HUP0004334A3 (en) | Substituted 1,2,3,4-tetrahydronaphthalene derivatives, process for producing them and pharmaceutical compositions containing them | |
HUT63163A (en) | Process for producing anxiety relieving bis-azabicyclo compounds and pharmaceutical compositions comprising same as active ingredient | |
EP0861084A4 (en) | PROCESS IMPROVEMENT AND COMPOSITION APPLICABLE TO THERAPEUTIC CISPLATIN (CDDP) | |
AU7929391A (en) | New 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles and 1,2,3,4-tetrahydro-beta-carbolines processes for preparing these and pharmaceutical compositions containing them | |
GB0008411D0 (en) | Pharmaceutical preparations and their manufacture | |
HU9402292D0 (en) | New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component | |
AU2923389A (en) | A pharmaceutical composition | |
HUT50844A (en) | Process for producing new 2'-halogen methylidene, 2'-ethenylidene and 2'-ethinyladenosine derivatives and pharmaceutical compositions comprising same as active ingredient | |
HUT55004A (en) | Process for producing 1,3-disubstituted 5-aryl-carbamoyl-4(6)-oxo-6(4)-oxido-pyrimidine-betaine derivatives and anthelmintic compositions containing them as active components | |
PL371340A1 (en) | Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations | |
HUT61024A (en) | Process for producing 10(1-hydroxyethyl)-11-oxo-1-aza-tricyclo/7.2.0.0.3.8/undex-2-ene-2-carboxylic acid esters and pharmaceutical compositions comprising same as active ingredient | |
EP0770423A3 (en) | Apparatus and method for continuously granulating powder material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |